COMMUNIQUÉS West-GlobeNewswire
-
Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
15/09/2026 -
Egle Therapeutics to Present Clinical Data at the Upcoming European Academy of Dermatology and Venereology (EADV) Congress in Vienna
15/09/2026 -
FDA Launches Expedited IND Pilot, Begins Accepting Applications
15/09/2026 -
AscellaHealth Advances AscellaOne Technology Strategy, Names Asad Shoostry Chief Technology Officer
15/09/2026 -
Lanier Recovery Center earns Joint Commission accreditation
15/09/2026 -
AliveCor Launches KardiaACCESS: A Medicare-Covered Program Built to Improve Blood Pressure, Diabetes, and Heart Health
15/09/2026 -
Le KFSH de Riyad ne relève aucun constat à haut risque sur près de 1 800 critères évalués lors du renouvellement de son accréditation JCI
15/09/2026 -
Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
15/09/2026 -
Ally Medical ER Collects More Than 16,000 Items for Texas Shelter Pets
15/09/2026 -
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
15/09/2026 -
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
15/09/2026 -
AMA and Atalan Launch Collaboration to Advance Physician Retention Research
15/09/2026 -
Peer-Reviewed Study of Lifeward’s ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain
15/09/2026 -
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
15/09/2026 -
Orvida Pharma Announces Interim Financing Led by Recordati to Advance Ontivatrep Development for Rare Genetic Skin Diseases
15/09/2026 -
BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
15/09/2026 -
Avicanna to Present at a Life Sciences Investor Forum on September 17, 2026
15/09/2026 -
Ontario Healthcare Stakeholders Unite on Shared Action Plan to Reduce Tobacco and Nicotine Dependence
15/09/2026 -
Axiom Biosciences Expands Manufacturing and Clinical Development Capabilities Through Partnership with GeneFab
15/09/2026
Pages